Replies to post #209793 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Yes hint, hint, hint of early approval.

Notice also the low dose of 5mg combined with the fact that these 6 patients were 18 or over and presumably already suffered extensive neurological damage.

It is a small study and not placebo controlled, but the many correlated measures are very suggestive.

Exciting to see how it will go with the Pediatric study!!!